Entrada Therapeutics Inc

Research Entrada Therapeutics Inc (TRDA) on Bullrun: market cap USD 299.31M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerTRDA
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 299.31M
• Financial periodFY2025
• RevenueUSD 25.42M
• Revenue growth-87.9%
• Net income-USD 143.75M
• Free cash flow-USD 129.55M

Valuation Snapshot

latest market cap is USD 299.31M.

About Entrada Therapeutics Inc

Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle, therapeutic candidates are based on a novel therapeutic; a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases. Its preclinical product includes ENTR-601-44; ENTR-601-45;

Frequently asked questions

What is Entrada Therapeutics Inc's market cap?

Entrada Therapeutics Inc's market capitalization is USD 299.31M.

What does Entrada Therapeutics Inc do?

Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible.